(Releads with Stryker denial)
By Francesco Canepa and Sudip Kar-Gupta
LONDON May 28 U.S. medical devices manufacturer Stryker Corp has denied any intention of making a bid for UK rival Smith & Nephew Plc, whose shares had spiked higher after a report that Stryker was planning a bid.
"At the request of the UK Takeover Panel, Stryker confirms that it does not intend to make an offer for Smith & Nephew," Stryker said in a statement on Wednesday, referring to the regulatory body in charge of takeovers in Britain.
Smith & Nephew shares had earlier jumped 17.5 percent to a record high of 1,120 pence, but the shares lost ground after Stryker's denial to be up just 2.3 percent by 1335 GMT.
Trading volume in Smith & Nephew shares also surged, coming in at four times the stock's three-month daily average.
The Financial Times had earlier reported on its website that Stryker was preparing a bid for Smith & Nephew, adding any offer would likely be some way above the London-based group's stock market value.
Analysts have frequently speculated Smith & Nephew may attract takeover interest. In 2010, Johnson & Johnson approached Smith & Nephew on a possible offer, according to people familiar with the matter.
($1 = 0.5952 British Pounds) (Additional reporting by Sudip Kar-Gupta, Vikram Subhedar and Sarah Young; Editing by Keiron Henderson and David Holmes)
Casino stocks fall after report of ATM cash withdrawal limit in Macau
Dec 8 Macau was preparing to slash in half the amount of cash China UnionPay bank card holders can withdraw from ATM machines in the city, the South China Morning Post reported, citing a finance industry source, sending shares of U.S. casino operators down.
Citron calls Express Scripts culprit in drug price gouging
Dec 8 Short seller Citron's Andrew Left has turned his sights on Express Scripts Holding Co, calling the pharmacy benefit manager (PBM) the "real culprit behind pharmaceutical price gouging."